Poonawalla Fincorp Taps Jefferies, Kotak, and JP Morgan to Lead ₹5,500 Crore Equity Fundraise

Poonawalla Fincorp is preparing to raise up to ₹5,500 crore through an equity issue. The board gave an in-principle approval to the proposal on January 16, as per Moneycontrol report. The company said the issue may be carried out through a qualified institutional placement or other permitted routes. 

The proposal still requires shareholder approval. After that, the company will have a 12-month window to complete the transaction. The planned raise is intended to support its lending book and capital needs. 

Three Banks Shortlisted 

As per the report, the company has approached 3 investment banks for the deal. Jefferies, Kotak Mahindra Capital, and JP Morgan have been shortlisted to work on the proposed issue. 

The capital is expected to be used as growth funding. The people cited in the reports did not wish to be named as the process is not public. 

Company Statement 

In response to queries, the company said its board had approved a fundraising of up to ₹5,500 crore through equity, including a QIP, subject to shareholder approval.  

For the quarter ended December 31, 2025, the company reported a net profit of ₹150.22 crore on revenue of ₹1,818.42 crore. Assets under management were ₹55,017 crore at the end of the quarter, with a workforce of 5,264 employees. 

Earlier Promoter Funding 

In July 2025, the company approved a ₹1,500 crore capital infusion from promoter entity Rising Sun Holdings through a preferential allotment. Adar Poonawalla, chief executive of Serum Institute of India, is the chairman of the board. 

Read More: Poonawalla Fincorp Launches Five AI Solutions to Drive Digital Transformation! 

Poonawalla Fincorp Share Price Performance  

As of February 9, 2026, 11:17 am, Poonawalla Fincorp share price was trading at ₹438, a 1.51% increase from the previous closing price. 

Conclusion  

The proposed equity issue remains subject to shareholder approval and market conditions. The company will have up to 12 months to complete the fundraising after approvals. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.   
 
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.